Stock listing
Stuttgart:C26 CellaVision AB Aktie
German listing (Stuttgart) of CellaVision AB · home listing Stockholm:CEVI
Follow CellaVision AB into a list and get an email when it puts out news.
Home listing price · OMXSTO:CEVI
201.50 SEK -2.00 (-1.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:CEVI
- Day range
- 198.40 – 203.50 SEKNov 20, 2026
- Volume
- 25,687 sharesNov 20, 2026
- Market cap
- 4.81B SEKAt the close on Nov 20, 2026 · price × 23.85M shares outstanding
- 52-week range
- 117.60 – 207.00 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 6.76M SEKMedian day 24,624 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:CEVI · Home | 201.50 SEK | -2.00 (-1.0%) | 25,687 | 200.50 | 203.50 | 198.40 | 203.50 | Close on Nov 20, 2026 |
| Frankfurt:C26 | €17.74 EUR | -0.28 (-1.6%) | — | €18.02 | €18.02 | €17.74 | €18.02 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:CEVI · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 201.50 | -2.00 | -1.0% | 200.50 | 203.50 | 198.40 | 25,687 | |
| 203.50 | +1.00 | +0.5% | 203.00 | 206.00 | 202.00 | 23,328 | |
| 202.50 | -1.00 | -0.5% | 202.50 | 207.00 | 202.00 | 27,871 | |
| 203.50 | 0.00 | 0.0% | 204.00 | 207.00 | 203.00 | 29,437 | |
| 203.50 | +1.50 | +0.7% | 200.50 | 206.00 | 200.50 | 23,341 | |
| 202.00 | -0.50 | -0.2% | 199.80 | 205.00 | 198.80 | 23,718 | |
| 202.50 | +3.50 | +1.8% | 204.50 | 204.50 | 201.00 | 18,762 | |
| 199.00 | +1.00 | +0.5% | 197.00 | 201.00 | 195.20 | 101,123 | |
| 198.00 | -1.80 | -0.9% | 199.80 | 204.00 | 198.00 | 45,042 | |
| 199.80 | +8.80 | +4.6% | 190.80 | 200.00 | 189.20 | 79,708 | |
| 191.00 | -0.40 | -0.2% | 190.00 | 193.40 | 189.00 | 29,876 | |
| 191.40 | -4.20 | -2.1% | 196.00 | 197.60 | 190.40 | 43,744 | |
| 195.60 | +7.80 | +4.2% | 189.00 | 198.20 | 189.00 | 61,605 | |
| 187.80 | +13.00 | +7.4% | 186.00 | 188.00 | 178.20 | 445,626 | |
| 174.80 | +4.00 | +2.3% | 172.20 | 178.00 | 169.80 | 37,300 | |
| 170.80 | -0.20 | -0.1% | 171.00 | 173.40 | 168.60 | 23,658 | |
| 171.00 | +1.20 | +0.7% | 169.80 | 172.80 | 167.60 | 24,637 | |
| 169.80 | -0.20 | -0.1% | 168.80 | 170.80 | 167.80 | 27,546 | |
| 170.00 | +5.00 | +3.0% | 165.80 | 170.60 | 164.80 | 24,610 | |
| 165.00 | +1.20 | +0.7% | 164.00 | 168.00 | 162.20 | 40,452 | |
| 163.80 | -2.20 | -1.3% | 165.00 | 167.00 | 163.80 | 26,796 | |
| 166.00 | -2.40 | -1.4% | 167.60 | 168.40 | 165.00 | 16,721 | |
| 168.40 | +1.80 | +1.1% | 166.20 | 168.40 | 165.60 | 24,153 | |
| 166.60 | +2.20 | +1.3% | 164.60 | 167.00 | 160.80 | 44,340 | |
| 164.40 | -1.40 | -0.8% | 165.80 | 166.80 | 163.20 | 74,794 | |
| 165.80 | +2.60 | +1.6% | 163.60 | 166.40 | 163.60 | 24,006 | |
| 163.20 | +1.40 | +0.9% | 162.00 | 166.40 | 160.60 | 17,677 | |
| 161.80 | -3.40 | -2.1% | 167.00 | 168.20 | 161.60 | 23,355 | |
| 165.20 | -3.60 | -2.1% | 173.00 | 173.00 | 164.00 | 17,828 | |
| 168.80 | -1.80 | -1.1% | 169.40 | 171.20 | 168.00 | 14,283 | |
| 170.60 | +2.80 | +1.7% | 169.60 | 172.80 | 169.60 | 50,180 | |
| 167.80 | -0.80 | -0.5% | 169.60 | 172.80 | 167.20 | 21,755 | |
| 168.60 | -3.80 | -2.2% | 172.40 | 172.60 | 168.60 | 11,885 | |
| 172.40 | -0.80 | -0.5% | 173.40 | 175.40 | 171.20 | 18,172 | |
| 173.20 | -3.00 | -1.7% | 177.20 | 179.40 | 173.00 | 19,098 | |
| 176.20 | +3.60 | +2.1% | 173.60 | 178.00 | 173.60 | 26,833 | |
| 172.60 | -2.20 | -1.3% | 177.20 | 180.60 | 172.60 | 39,342 | |
| 174.80 | +8.40 | +5.0% | 165.80 | 174.80 | 165.80 | 29,471 | |
| 166.40 | -1.60 | -1.0% | 166.20 | 170.00 | 165.80 | 9,296 | |
| 168.00 | +1.40 | +0.8% | 164.80 | 168.00 | 164.80 | 51,788 | |
| 166.60 | -0.20 | -0.1% | 165.60 | 167.80 | 163.40 | 25,755 | |
| 166.80 | +3.60 | +2.2% | 164.00 | 167.00 | 161.40 | 12,368 | |
| 163.20 | -1.80 | -1.1% | 165.00 | 166.20 | 163.00 | 10,019 | |
| 165.00 | +1.80 | +1.1% | 158.40 | 167.00 | 158.40 | 14,559 | |
| 163.20 | +2.20 | +1.4% | 161.00 | 163.20 | 159.60 | 14,391 | |
| 161.00 | 0.00 | 0.0% | 161.40 | 161.60 | 158.20 | 15,712 | |
| 161.00 | -0.40 | -0.2% | 161.40 | 163.00 | 160.20 | 18,353 | |
| 161.40 | +3.20 | +2.0% | 158.00 | 161.60 | 157.00 | 160,469 | |
| 158.20 | -2.80 | -1.7% | 161.60 | 162.40 | 158.00 | 14,971 | |
| 161.00 | -1.20 | -0.7% | 162.20 | 163.20 | 159.60 | 36,539 | |
| 162.20 | +0.20 | +0.1% | 162.80 | 164.40 | 162.00 | 20,666 | |
| 162.00 | +1.60 | +1.0% | 161.40 | 164.40 | 160.40 | 33,231 | |
| 160.40 | -2.20 | -1.4% | 163.00 | 163.80 | 157.60 | 27,807 | |
| 162.60 | -0.20 | -0.1% | 163.00 | 164.20 | 158.60 | 29,805 | |
| 162.80 | -1.80 | -1.1% | 164.60 | 166.00 | 162.80 | 21,168 | |
| 164.60 | -1.80 | -1.1% | 168.20 | 168.20 | 164.40 | 22,528 | |
| 166.40 | +2.20 | +1.3% | 164.40 | 168.40 | 164.00 | 22,608 | |
| 164.20 | -0.60 | -0.4% | 166.00 | 166.40 | 164.00 | 14,358 | |
| 164.80 | +0.80 | +0.5% | 163.80 | 165.40 | 163.60 | 28,373 | |
| 164.00 | 0.00 | 0.0% | 164.00 | 165.80 | 163.60 | 11,993 | |
| 164.00 | -3.40 | -2.0% | 169.20 | 169.40 | 163.60 | 25,988 | |
| 167.40 | +3.80 | +2.3% | 164.00 | 170.40 | 162.00 | 35,410 | |
| 163.60 | +1.40 | +0.9% | 162.20 | 167.40 | 160.60 | 90,522 | |
| 162.20 | +5.40 | +3.4% | 156.40 | 162.20 | 155.80 | 18,865 |
- Ticker
- Stuttgart:C26
- Asset type
- Stock
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Jun 5, 2026
The Board of CellaVision AB appoints Steve Ferguson as CEO
Latest earnings call · Jul 17, 2026
CellaVision (Stockholm:CEVI) Q2 2026 Earnings Call
Replay and transcript
Latest deck · June 2026
Fact Sheet (June 2026)
Fact sheet · 2 slides
Latest news
The Board of CellaVision AB appoints Steve Ferguson as CEO
Jun 5, 2026
Closed 128.40 (+1.9%) on Jun 8, 2026
CellaVision publishes its 2025 Annual and Sustainability Report
Apr 1, 2026
Closed 154.20 (+0.4%) on Apr 1, 2026
CellaVision appoints Monica Jönsson as new CFO
Dec 12, 2025
Closed 153.20 (-0.4%) on Dec 12, 2025
CellaVision receives CE marking according to IVDR Class C for CellaVision® Bone Marrow Aspirate Application
Dec 8, 2025
Closed 152.20 (-2.6%) on Dec 8, 2025
CellaVision AB on 6ix
- News releases
- 4 in the last 12 months · 6 in all · newest Jun 5, 2026 · oldest 2025
- Calls
- 10 calls with a replay · 10 with a transcript · latest Jul 17, 2026
- Decks
- 28 decks · latest June 2026
Where CellaVision AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:CEVI · Home listing | Stockholm | Sweden | SEK |
| gettex:C26 | gettex | Germany | EUR |
| LSIN:0MR5 | LSIN | United Kingdom | SEK |
| OTC:CLVSF | OTC | United States | USD |
| OTC:CVLLY | OTC | United States | USD |
| LS Exchange:A0NEVD | LS Exchange | Germany | EUR |
| Lang & Schwarz:A0NEVD | Lang & Schwarz | Germany | EUR |
| Frankfurt:C26 | Frankfurt | Germany | EUR |
| Aquis:CEVIS | Aquis | United Kingdom | SEK |
| Munich:C26 | Munich | Germany | EUR |
| Stuttgart:C26 · This page | Stuttgart | Germany | EUR |
| Aquis:CEVIS | Aquis | United Kingdom | SEK |
| Dusseldorf:C26 | Dusseldorf | Germany | EUR |
| Turquoise:CEVIS | Turquoise | United Kingdom | SEK |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- 4.64B SEK
- P/E
- 34.9×
- EV/sales
- 6.1×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 5.2×
- Gross margin
- 68.0%
- Operating margin
- 23.0%
- Net margin
- 18.1%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Forecasts
Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 198.33 SEK · Analysts' mean
- EPS, year to Dec 2026
- 6.20 · 3 analysts
- Revenue, year to Dec 2026
- 787.6M · 3 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Steve Ferguson | CEO |
| Monica Jönsson | CFO |
| Helena Raihle | Corporate Communications & Investor Relations |
Board
| Director | Role |
|---|---|
| Zlatko Rihter | Chairman |
Events
- Next results
- Feb 3, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| CellaVision (Stockholm:CEVI) Q2 2026 Earnings Call | Fri, Jul 17, 2026 · 5:00 AM ET | Replay |
| CellaVision (Stockholm:CEVI) Q1 2026 Earnings Call | Fri, Apr 24, 2026 · 5:00 AM ET | Replay |
| CellaVision (Stockholm:CEVI) Q4 2025 Earnings Call | Thu, Feb 05, 2026 · 5:00 AM ET | Replay |
| CellaVision (Stockholm:CEVI) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 5:00 AM ET | Replay |
| CellaVision (Stockholm:CEVI) Q2 2025 Earnings Call | Fri, Jul 18, 2025 · 5:00 AM ET | Replay |
| CellaVision (Stockholm:CEVI) Q1 2025 Earnings Call | Tue, Apr 29, 2025 · 1:20 AM ET | Replay |
| CellaVision (Stockholm:CEVI) Q4 2024 Earnings Call | Thu, Feb 06, 2025 · 1:20 AM ET | Replay |
| CellaVision (Stockholm:CEVI) Q3 2024 Earnings Call | Thu, Oct 24, 2024 · 1:20 AM ET | Replay |
| CellaVision (Stockholm:CEVI) Q2 2024 Earnings Call | Fri, Jul 19, 2024 · 1:20 AM ET | Replay |
| CellaVision (Stockholm:CEVI) Q1 2024 Earnings Call | Thu, Apr 25, 2024 · 1:20 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 28, 2026 · After close | +7.4% |
| Q2 2026 | Jul 17, 2026 · Before open | +7.8% |
| Q1 2026 | Apr 24, 2026 · Before open | −21.5% |
| Q4 2025 | Feb 4, 2026 · After close | +11.3% |
| Q3 2025 | Nov 6, 2025 · Before open | −9.1% |
| Q2 2025 | Jul 18, 2025 · Before open | +1.4% |
| Q1 2025 | Apr 29, 2025 · Before open | +22.7% |
| Q4 2024 | Feb 6, 2025 · Before open | −7.9% |
| Q3 2024 | Oct 24, 2024 · Before open | +1.4% |
| Q2 2024 | Jul 19, 2024 · Before open | −7.7% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Apr 25, 2024 · Before open | −4.4% |
| Q4 2023 | Feb 7, 2024 · Before open | +18.6% |
| Q3 2023 | Oct 25, 2023 · Before open | −4.3% |
| Q2 2023 | Jul 20, 2023 · Before open | +13.4% |
| Q1 2023 | May 4, 2023 · Before open | −1.2% |
| Q4 2022 | Feb 8, 2023 · Before open | −6.4% |
| Q3 2022 | Oct 26, 2022 · Before open | −22.3% |
| Q2 2022 | Jul 20, 2022 · Before open | +1.9% |
| Q1 2022 | May 10, 2022 · Before open | −0.5% |
| Q4 2021 | Feb 4, 2022 · Before open | +1.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Fact Sheet (June 2026) | Fact sheet | 2 slides | June 2026 |
| Q1 2026 Earnings Presentation | Earnings | 19 slides | Apr 24, 2026 |
| Fact Sheet (March 2026) | Fact sheet | 2 slides | March 2026 |
| Q4 2025 Earnings Presentation | Earnings | 18 slides | Feb 5, 2026 |
| Q2 2025 Earnings Presentation | Earnings | 7 slides | Jul 18, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 18 slides | Apr 29, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 18 slides | Feb 6, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 19 slides | Oct 24, 2024 |
| Fact Sheet (October 2024) | Fact sheet | 2 slides | October 2024 |
| Q2 2024 Earnings Presentation | Earnings | 18 slides | Jul 19, 2024 |
All 28 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 2024 Earnings Presentation | Earnings | 18 slides | Apr 25, 2024 |
| Fact Sheet (October 2022) | Fact sheet | 8 slides | October 2022 |
| Fact Sheet (October 2022) | Fact sheet | 2 slides | October 2022 |
| Investor Day (October 2022) | Investor day | 84 slides | October 2022 |
| Fact Sheet (September 2022) | Fact sheet | 2 slides | September 2022 |
| Fact Sheet (September 2022) | Fact sheet | 2 slides | September 2022 |
| Fact Sheet (August 2022) | Fact sheet | 2 slides | August 2022 |
| Fact Sheet (August 2022) | Fact sheet | 2 slides | August 2022 |
| Shareholder Meeting (May 2015) | Shareholder meeting | 18 slides | May 21, 2015 |
| Shareholder Meeting (May 2014) | Shareholder meeting | 20 slides | May 12, 2014 |
| Shareholder Meeting (April 2013) | Shareholder meeting | 24 slides | Apr 24, 2013 |
| Shareholder Meeting (April 2013) | Shareholder meeting | 24 slides | Apr 24, 2013 |
| Shareholder Meeting (May 2012) | Shareholder meeting | 21 slides | May 2, 2012 |
| Shareholder Meeting (2011) | Shareholder meeting | 19 slides | 2011 |
| Investor Presentation (April 2010) | Investor deck | 18 slides | Apr 29, 2010 |
| Investor Presentation (April 2010) | Investor deck | 18 slides | Apr 29, 2010 |
| Shareholder Meeting (April 2009) | Shareholder meeting | 19 slides | Apr 27, 2009 |
| Shareholder Meeting (April 2009) | Shareholder meeting | 19 slides | Apr 27, 2009 |
Financials
Annual, in SEK
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 759.0M | 723.2M | 677.3M | 639.3M | 565.6M | 471.4M | 461.8M | 364.8M | 309.3M | 265.0M |
| Cost of revenue | 239.1M | 236.1M | 214.3M | 201.0M | 173.3M | 158.4M | 125.0M | 93.9M | 86.1M | 76.1M |
| Gross profit | 519.9M | 487.1M | 463.0M | 438.3M | 392.3M | 313.0M | 336.7M | 270.9M | 223.2M | 188.9M |
| Research and development | 97.6M | 87.4M | 83.3M | 88.6M | 64.2M | 51.3M | 56.4M | 39.3M | 26.8M | 29.2M |
| Selling, general and administrative | 90.3M | 85.4M | 76.0M | 73.5M | 63.1M | 51.0M | 51.4M | 37.6M | 35.6M | 28.7M |
| Operating income | 202.1M | 177.7M | 167.1M | 158.3M | 162.7M | 110.3M | 126.6M | 111.6M | 90.9M | 74.2M |
| Depreciation and amortization | 32.3M | 41.0M | 39.8M | 40.1M | 33.4M | 32.0M | 20.2M | 6.81M | 8.45M | 8.26M |
| EBITDA | 234.4M | 218.7M | 206.8M | 198.4M | 196.2M | 142.3M | 146.7M | 118.4M | 99.3M | 82.4M |
| Interest expense | 10.7M | 8.16M | 3.26M | 2.34M | 1.87M | 2.55M | 1.50M | 159.0K | 158.0K | 37.0K |
| Income before tax | 194.3M | 176.9M | 164.2M | 148.4M | 158.3M | 112.2M | 129.2M | 112.1M | 90.3M | 75.8M |
| Income tax | 41.2M | 36.1M | 33.9M | 30.1M | 33.0M | 22.7M | 30.0M | 23.4M | 20.6M | 16.0M |
| Net income | 153.1M | 140.7M | 130.3M | 118.3M | 125.3M | 89.5M | 99.2M | 88.7M | 69.7M | 59.8M |
| Earnings per share, basic | 6.42 | 5.90 | 5.46 | 4.96 | 5.25 | 3.75 | 4.16 | 3.72 | 2.92 | 2.51 |
| Earnings per share, diluted | 6.42 | 5.90 | 5.46 | 4.96 | 5.25 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 188.2M | 149.4M | 121.6M | 108.1M | 130.3M | 102.3M | 102.3M | 169.1M | 154.5M | 132.5M |
| Short-term investments | -5.15M | -21.8M | -17.2M | -17.9M | ||||||
| Receivables | 141.1M | 128.6M | 117.9M | 126.5M | 119.3M | 100.4M | 104.6M | 85.0M | 54.0M | 44.0M |
| Inventory | 111.8M | 124.8M | 126.0M | 142.6M | 115.1M | 83.7M | 54.8M | 34.5M | 28.8M | 36.3M |
| Current assets | 441.1M | 402.8M | 365.6M | 377.1M | 364.7M | 298.1M | 265.3M | 294.6M | 239.4M | 216.4M |
| Property, plant and equipment | 122.4M | 119.9M | 125.5M | 110.0M | 80.3M | 47.4M | 54.5M | 6.82M | 4.81M | 3.27M |
| Goodwill | 120.7M | 128.1M | 123.8M | 124.1M | 114.1M | 112.0M | 115.1M | |||
| Total assets | 1.09B | 1.01B | 928.7M | 891.7M | 825.2M | 668.0M | 641.7M | 372.8M | 300.6M | 256.4M |
| Accounts payable | 35.7M | 32.2M | 32.5M | 47.9M | 44.9M | 20.9M | 21.7M | 26.8M | 21.5M | 16.5M |
| Current liabilities | 110.9M | 109.1M | 119.2M | 133.1M | 134.5M | 104.1M | 125.9M | 71.9M | 51.1M | 50.3M |
| Long-term debt | 12.0M | 12.7M | 28.7M | 60.4M | 95.8M | 86.9M | 122.9M | |||
| Total debt | 25.7M | 26.8M | 64.7M | 102.5M | 136.7M | 132.8M | 173.7M | 4.83M | 1.63M | 5.05M |
| Total liabilities | 207.3M | 196.2M | 212.3M | 250.1M | 281.9M | 238.4M | 293.3M | 82.4M | 59.7M | 50.3M |
| Shareholders' equity | 887.6M | 815.7M | 716.4M | 641.6M | 543.3M | 429.6M | 348.4M | 290.4M | 240.9M | 206.2M |
| Shares outstanding | 23.9M | 23.9M | 23.9M | 23.9M | 23.9M | 23.9M | 23.9M | 23.9M | 23.9M | 23.9M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 200.5M | 198.4M | 196.4M | 137.3M | 159.7M | 71.1M | 126.0M | 74.1M | 87.9M | 76.6M |
| Capital spending | -18.8M | -12.0M | -31.8M | -23.5M | -13.7M | -33.7M | -18.7M | -22.0M | -29.1M | -14.2M |
| Free cash flow | 181.7M | 186.4M | 164.7M | 113.8M | 146.0M | 37.5M | 107.3M | 52.1M | 58.8M | 62.4M |
| Cash from investing | -86.2M | -76.0M | -85.5M | -70.0M | -84.3M | -35.0M | -266.3M | -23.9M | -29.7M | -15.0M |
| Cash from financing | -74.6M | -95.1M | -97.0M | -90.4M | -48.5M | -35.2M | 73.0M | -35.8M | -35.8M | -35.8M |
| Dividends paid | -59.6M | -53.7M | -53.7M | -47.7M | -17.9M | -17.9M | -35.8M | -35.8M | -35.8M | -35.8M |
| Change in cash | 39.8M | 27.3M | 13.9M | -23.1M | 26.9M | -50.0K | -66.7M | 14.5M | 22.1M | 25.8M |
Cap table
Built by 6ix from CellaVision AB’s releases
- Common shares
- 23,851,547
- Fully diluted
- 23,851,547
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 23,851,547 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 23,851,547 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Helena Raihle | Corporate Communications & Investor Relations · Since at least Apr 1, 2026 |
| Monica Jönsson | CFO · Since at least Dec 12, 2025 |
| Steve Ferguson | CEO · Since Jun 5, 2026 · Appointed, no departure found |
| Steve Ferguson | CEO · Since at least Jun 5, 2026 |
| Zlatko Rihter | Chairman · Since at least Jun 5, 2026 |
Log in to ask 6ix AI your own questions about CellaVision AB.